A wide variety of candidate markers are available for the detection of prostate carcinoma cells, most notably prostate-specific antigen (PSA) and prostate-specific membrane antigen, which are both clinically relevant to prostate cancer (although PSA itself is a secreted protein, its production can be detected within prostate cancer cells) [15]. This evidence concerns the gene FOLH1 and prostate carcinoma.